arXiv subjects

Zhenfeng Deng

Publications and source records attributed to Zhenfeng Deng.

3 recordsLinked to original sources

arXiv2026

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

cs.AI↗

arXiv2026

Fair splits flip the leaderboard: CHANRG reveals limited generalization in RNA secondary-structure prediction

Accurate prediction of RNA secondary structure underpins transcriptome annotation, mechanistic analysis of non-coding RNAs, and RNA therapeutic design. Recent gains from deep learning and RNA foundation models are difficult to interpret because current benchmarks may overestimate generalization across RNA families. We present the Comprehensive Hierarchical Annotation of Non-coding RNA Groups (CHANRG), a benchmark of 170{,}083 structurally non-redundant RNAs curated from more than 10 million sequences in Rfam~15.0 using structure-aware deduplication, genome-aware split design and multiscale structural evaluation. Across 29 predictors, foundation-model methods achieved the highest held-out accuracy but lost most of that advantage out of distribution, whereas structured decoders and direct neural predictors remained markedly more robust. This gap persisted after controlling for sequence length and reflected both loss of structural coverage and incorrect higher-order wiring. Together, CHANRG and a padding-free, symmetry-aware evaluation stack provide a stricter and batch-invariant framework for developing RNA structure predictors with demonstrable out-of-distribution robustness.

q-bio.BM↗

arXiv2025

Discontinuous Epitope Fragments as Sufficient Target Templates for Efficient Binder Design

Recent advances in structure-based protein design have accelerated de novo binder generation, yet interfaces on large domains or spanning multiple domains remain challenging due to high computational cost and declining success with increasing target size. We hypothesized that protein folding neural networks (PFNNs) operate in a ``local-first'' manner, prioritizing local interactions while displaying limited sensitivity to global foldability. Guided by this hypothesis, we propose an epitope-only strategy that retains only the discontinuous surface residues surrounding the binding site. Compared to intact-domain workflows, this approach improves in silico success rates by up to 80% and reduces the average time per successful design by up to forty-fold, enabling binder design against previously intractable targets such as ClpP and ALS3. Building on this foundation, we further developed a tailored pipeline that incorporates a Monte Carlo-based evolution step to overcome local minima and a position-specific biased inverse folding step to refine sequence patterns. Together, these advances not only establish a generalizable framework for efficient binder design against structurally large and otherwise inaccessible targets, but also support the broader ``local-first'' hypothesis as a guiding principle for PFNN-based design.

q-bio.BM↗